On this last question, I will only add that when there is a change in market status in a foreign country, in Europe or the U.S., for example, the first thing that a manufacturer in Canada will do is notify Health Canada and have a discussion with them about what the appropriate response for the Canadian approval would be.
On June 12th, 2014. See this statement in context.